Q4 2023 Holdings
Filed 2025-02-13 | 16 holdings | $327.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| HilleVax, Inc. | COM | 43157M102 | $107.9M | 6,724,000 | 33.0% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $86.9M | 4,214,559 | 26.5% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $77.4M | 7,459,286 | 23.6% |
| Ovid Therapeutics Inc.(OVID) | COM | 690469101 | $24.3M | 7,531,996 | 7.4% |
| Shattuck Labs, Inc.(STTK) | COM | 82024L103 | $14.9M | 2,090,858 | 4.6% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $7.6M | 1,346,892 | 2.3% |
| American Well Corp(AMWL) | COM CL A NEW | 03044L204 | $2.3M | 1,554,669 | 0.7% |
| Turnstone Biologics Corp. | COM | 90042W100 | $2.3M | 895,824 | 0.7% |
| Equillium, Inc.(EQ) | COM | 29446K106 | $1.3M | 1,824,977 | 0.4% |
| Rani Therapeutics Holdings, Inc.(RANI) | COM CL A | 753018100 | $1.1M | 338,679 | 0.3% |
| Xilio Therapeutics, Inc.(XLO) | COM | 98422T100 | $811.3K | 1,475,121 | 0.2% |
| Akili, Inc. | COMMON STOCK | 00974B107 | $359.8K | 738,819 | 0.1% |
| Aerovate Therapeutics, Inc. | COM | 008064107 | $307.3K | 13,580 | 0.1% |
| Standard Biotools Inc.(LAB) | COM | 34385P108 | $36.5K | 16,515 | 0.0% |